Cargando…
New insights into YAP/TAZ nucleo‐cytoplasmic shuttling: new cancer therapeutic opportunities?
Yes‐associated protein (YAP) and transcriptional co‐activator with PDZ‐binding motif (TAZ), the main effectors of the Hippo pathway, are emerging as important players in cancer biology and therapy response. The intracellular localization of YAP/TAZ is a key determinant in the regulation of their act...
Autores principales: | Shreberk‐Shaked, Michal, Oren, Moshe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547617/ https://www.ncbi.nlm.nih.gov/pubmed/31050214 http://dx.doi.org/10.1002/1878-0261.12498 |
Ejemplares similares
-
Deciphering the involvement of the Hippo pathway co-regulators, YAP/TAZ in invadopodia formation and matrix degradation
por: Venghateri, Jubina Balan, et al.
Publicado: (2023) -
An optogenetic method for interrogating YAP1 and TAZ nuclear–cytoplasmic shuttling
por: Dowbaj, Anna M., et al.
Publicado: (2021) -
SUMOylation regulates nucleo-cytoplasmic shuttling of Elk-1
por: Salinas, Sara, et al.
Publicado: (2004) -
New insights into the ambivalent role of YAP/TAZ in human cancers
por: Luo, Juan, et al.
Publicado: (2023) -
Interphase Nucleo-Cytoplasmic Shuttling and Localization of SIRT2 during Mitosis
por: North, Brian J., et al.
Publicado: (2007)